Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.6.6 from v3.6.5. This marks a minor site update and does not modify the study data or page content.
    Difference
    0.0%
    Check dated 2026-08-30T00:38:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, signaling a minor version update rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:23.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added (replacing v3.6.3), reflecting an administrative update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T18:17:24.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.3, replacing the previous v3.6.2; this indicates a minor page version update to the study record.
    Difference
    0.0%
    Check dated 2026-07-04T13:23:37.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, indicating a minor update to the ClinicalTrials.gov entry. The change reflects version control or backend adjustments rather than substantive changes to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-06-27T07:40:14.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The study record now shows 'No longer looking for participants', indicating termination due to poor accrual and no further enrollment. Additionally, the page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision stamp from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T01:12:16.000Z thumbnail image

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.